- Endoscopic retrograde cholangiopancreatography (ERCP) is safe and provides clinically useful diagnostic information in the pediatric patient population.
Why this matters
- ERCP is an endoscopic diagnostic procedure used every day in adult populations to evaluate the pancreatic and bile ducts.
- Little data from clinical trials have been available for ERCP in the pediatric population.
- This is the first multicenter, prospective study of its kind.
- Multicenter prospective study including participation of 15 IRB approved clinics.
- The study evaluated 1124 ERCP procedures in 857 consecutive patients
- 803 (71.2%) procedures were performed on a native papilla.
- The mean age was 12.1 years, with only 5% of procedures performed on patients younger than 3 years of age.
- Adverse events were described using the American Society of Gastrointestinal Endoscopy lexicon.
- Biliary indications were most common, accounting for 76.4% of cases. Pancreatic indications accounted for 27.6% of cases.
- Overall technical success was achieved in 1017 (90.5%) cases.
- Adverse events were documented in 107 (9.5%) cases.
- Post-ERCP pancreatitis was the most common adverse event, occurring in 5% of cases, similar to what is seen in adult populations.